Check out the latest brokerage calls and analyst comments on the stocks in action today. Our coverage includes HDFC Bank, Persistent Systems, and HUL.
HDFC Bank
CLSA On HDFC Bank
Hold Call, Target At `1,785/Sh
Q3 Profit Before Tax In-line
Quarter Was More Of Same With Steady Deposit Growth
Curtailment Of Loan Growth, & Largely Stable NIM And Asset Quality
Bank Has Reduced Loan Growth To A 3% YoY & Has Brought LDR Down To 98%
Expect Loan Deposit Ratio To Reach 90% Only In FY27
NIM Moderated A Bit Sequentially, Which Is Par For Course In This Environment
On A YoY Basis, Gross Slippages Are 20 bps Higher - A Decent Performance
Macquarie On HDFC Bank
Outperform Call, Target At `2,300/Sh
Q3 Profit In-line: Decent Results In A Tough Macro Environment
Marginal Increase In Credit Costs Because Of Higher Agri Slippages
Management Expects NIM To Improve Once Macro Environment Improves
HSBC On HDFC Bank
Buy Call, Target Cut To `1,980/Sh From `2,130/Sh
Q3 Results In-line
NIM Compression & Stable Asset Quality Are Positives
Cut FY26-27 EPS Estimates By 4-5% To Reflect Lower Loan Growth
Inflection In Loan Growth Is Key
Bernstein On HDFC Bank
Outperform Call, Target At `2,300/Sh
Delivered A Good Set Of Numbers, Despite EPS Growth At 2% YoY
Decent NII Growth
Net Operating Income Growth Was Weak But Core Fee Income Remained Strong
Continued Opex Moderation Was Enough To Offset Weak NOI Growth
A YoY Profit Before Tax Growth Of 12% Leaves Us More Confident
Co May See Return To Mid-teens EPS Growth Trajectory In Quarters Ahead
Persistent Systems
Nomura On Persistent
Neutral Call, Target At `6,200/Sh
Resilient Growth In Q3 Driven By Strong Execution
Margin Improvement Provides Additional Comfort
Revenue Broadly In-line
Deal Wins Decent
Strong Execution Likely To Help Deliver Industry-Leading Growth
HSBC On Persistent
Hold Call, Target At `5,650/Sh
Co Successfully Accelerating Non-Healthcare Verticals, Which Is A Positive Surprise
Well Positioned To Grow At Industry-Leading Rate In FY26 As Well
Consensus Estimates Already Factor In This Both Growth & Margin Improvement
Citi On Persistent
Sell Call, Target Raised To `5,000/Sh
Reported Decent Q3; Revenue Was In-line, While Margin Were Better
Key Focus Areas Include 9-month CFO/EBITDA At 50%
Headcount Up 3% QoQ/ 2.5% YoY With Utilisation At Highest Ever Is Also Important
Revise FY25/FY26 EPS By 2-6% As Incorporate Earnings
Co Continues To Deliver Consistently
Valuations Are At 51x FY26 Cons EPS – Pricing In All Positives
HUL
GS On HUL
Neutral Call, Target At `2,480/Sh
Q3 Below Estimates On Volume & EBITDA Growth
Urban Slowdown Has Worsened, Downtrading To Small Packs Underway
Soap Volumes Decline Driven By High Price Increases And Grammage Cuts
EBITDA Margin Lower YoY Despite Low Ad Spends
CLSA On HUL
Underperform Call, Target Cut To `1,924/Sh
Weak Growth & Lower Margin In Q3
Three Of Four Segments See UVG Decline; Minimalist Acquisition Announced
FY25-27 EPS Cuts Of 4-6%
Margin To Weaken Especially For Beauty & Wellness As Growth In Focus
UBS On HUL
Neutral Call, Target At `2,700/Sh
Revenue Growth Broadly In-line; Weak Product Mix Impacts UVG
Volume Led Growth In Home Care; Price Hike Impacts Personal Care
Expect Near Term Demand To Remain Soft
Cut EPS Est For FY25-27 By 1-5% To Reflect Near Term Demand Weakness
Disclaimer: The views and investment tips expressed by investment experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.